Today: 11 June 2026
Chevron stock jumps after hours as Venezuela licence talks put CVX back in play
9 January 2026
1 min read

Chevron stock jumps after hours as Venezuela licence talks put CVX back in play

NEW YORK, Jan 8, 2026, 19:28 EST — After-hours

Chevron Corp shares rose 2.6% in after-hours trading on Thursday after a Reuters report said the oil major is in talks with Washington to expand its Venezuela licence, which could let it ship more crude to its refineries and sell to other buyers. The stock was at $159.25. Tighter terms imposed in July cut the company’s Venezuelan exports to about 100,000 barrels per day (bpd) in December from 250,000 earlier this year, sources said.

The talks land as the Trump administration pushes to take tighter control of Venezuela’s oil sales and revenue, and as it leans on firms to help move barrels and handle payments. The White House has invited the bosses of Vitol and Trafigura to talks on marketing Venezuelan oil on Friday, sources familiar with the matter told Reuters. Venezuela’s output has fallen to around 1 million bpd, about 1% of global supply, after years of under-investment and sanctions, the report said.

Crude prices, meanwhile, have stayed glued to the headlines. Brent settled up 3.4% at $61.99 a barrel and U.S. West Texas Intermediate ended up 3.2% at $57.76 on Thursday, both at two-week highs, Reuters reported. “The complex is rebounding,” analysts at Ritterbusch and Associates said. Reuters

Chevron is not alone in trying to secure a slot in any new export set-up. Sources said Chevron, Vitol, Trafigura and others are vying for U.S. government deals to export crude and market up to 50 million barrels that Venezuela’s state-run PDVSA has accumulated in inventories. Jean-Francois Lambert of consultancy Lambert Commodities said big traders bring “global reach and optionality the majors lack.” Reuters

In regular trading, the S&P 500 finished little changed on Thursday as investors looked ahead to Friday’s U.S. nonfarm payrolls report. Energy was the strongest sector on the day, helped by the jump in oil prices.

Still, the wider set-up for oil is not clean. Morgan Stanley analysts estimated the market could swing into a surplus of as much as 3 million bpd in the first half of 2026, and Venezuelan barrels have been offered at steep discounts. “Crude futures continuing on the defensive,” Dennis Kissler, senior vice president of trading at BOK Financial, said after Trump’s Venezuela comments helped push prices lower on Wednesday. Reuters

Chevron is scheduled to host its fourth-quarter earnings conference call on Jan. 30 at 11:00 a.m. EST. Investors are likely to press for detail on cash returns, refining margins and whether the Venezuela licence changes move from talks to paperwork.

Stock Market Today

  • Wall Street Gains on AI Stock Rally Amid Inflation and Middle East Tensions
    June 11, 2026, 11:16 AM EDT. Wall Street recovered some weekly losses Thursday as artificial intelligence (AI) stocks rebounded, led by chipmakers like Marvell Technology (+5.5%), Intel (+7.8%), and Applied Materials (+7.5%). The S&P 500 rose 0.5%, Dow Jones 0.7%, and Nasdaq 0.7%. Despite market gains, concerns about elevated AI valuations persist, while Oracle shares fell 11.1% after revealing plans to raise $40 billion to fund AI investments. Oil prices remained steady despite rising tensions in the Iran conflict, with Brent crude at $92.64 and U.S. crude at $90.29 per barrel. Meanwhile, wholesale inflation in the U.S. exceeded expectations in May, prompting the European Central Bank to raise interest rates, signaling global inflationary pressures.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Lockheed Martin stock jumps as Trump floats $1.5 trillion defense budget, buyback limits in focus
Previous Story

Lockheed Martin stock jumps as Trump floats $1.5 trillion defense budget, buyback limits in focus

Glencore stock jumps 8% on Rio Tinto merger talks as Feb 5 deadline looms
Next Story

Glencore stock jumps 8% on Rio Tinto merger talks as Feb 5 deadline looms

Go toTop